In the STEP 1 trial, semaglutide 2.4 mg produced roughly 15% average body-weight reduction over 68 weeks (NEJM 2021)
Safety Warnings Health authorities in the UK, Australia, and the U.S
doi: 10.1007/s12020-022-03064-1 38 DieneGAnguloMHalePMJepsenCHHofmanPLHokken-KoelegaAet al
Utilizzando la tecnologia di sequenziamento RNA-seq di nuova generazione, hanno confermato che il GHK-Cu modula l'espressione di 4.231 geni , di cui 2.861 sovra-regolati e 1.370 sotto-regolati
Stopping the medication may result in weight regain unless healthy lifestyle changes are maintained
These findings were isupported in humans by the observations that two SNPs of APOC3 (C-482 T, T-455C), leading to decreased APOC3 expression, were correlated with increased hepatic TG level and higher prevalence of NAFLD in Asian indian population [71]